233 related articles for article (PubMed ID: 26552829)
21. Multivalent comb-type aptamer-siRNA conjugates for efficient and selective intracellular delivery.
Yoo H; Jung H; Kim SA; Mok H
Chem Commun (Camb); 2014 Jun; 50(51):6765-7. PubMed ID: 24830507
[TBL] [Abstract][Full Text] [Related]
22. Stick-Based Methods for Aptamer-Mediated siRNA Targeted Delivery.
Catuogno S; Esposito CL; Giangrande PH
Methods Mol Biol; 2021; 2282():31-42. PubMed ID: 33928568
[TBL] [Abstract][Full Text] [Related]
23. Targeted lipoplexes for siRNA delivery.
Cardoso A; Trabulo S; Moreira JN; Düzgüneş N; de Lima MC
Methods Enzymol; 2009; 465():267-87. PubMed ID: 19913172
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of HIV-1 protease expression in T cells owing to DNA aptamer-mediated specific delivery of siRNA.
Zhu Q; Shibata T; Kabashima T; Kai M
Eur J Med Chem; 2012 Oct; 56():396-9. PubMed ID: 22907035
[TBL] [Abstract][Full Text] [Related]
25. Biophysical characterization of layer-by-layer synthesis of aptamer-drug microparticles for enhanced cell targeting.
Tan KX; Danquah MK; Sidhu A; Lau SY; Ongkudon CM
Biotechnol Prog; 2018 Jan; 34(1):249-261. PubMed ID: 28699244
[TBL] [Abstract][Full Text] [Related]
26. Design and Preparation of Aptamer-siRNA Chimeras (AsiCs) for Targeted Cancer Therapy.
Kruspe S; Giangrande PH
Methods Mol Biol; 2017; 1632():175-186. PubMed ID: 28730439
[TBL] [Abstract][Full Text] [Related]
27. Cell-specific aptamers and their conjugation with nanomaterials for targeted drug delivery.
Liao J; Liu B; Liu J; Zhang J; Chen K; Liu H
Expert Opin Drug Deliv; 2015 Mar; 12(3):493-506. PubMed ID: 25430795
[TBL] [Abstract][Full Text] [Related]
28. Methods for assembling B-cell lymphoma specific and internalizing aptamer-siRNA nanoparticles via the sticky bridge.
Zhou J; Rossi JJ; Shum KT
Methods Mol Biol; 2015; 1297():169-85. PubMed ID: 25896003
[TBL] [Abstract][Full Text] [Related]
29. Multivalent Aptamer-RNA Conjugates for Simple and Efficient Delivery of Doxorubicin/siRNA into Multidrug-Resistant Cells.
Jeong H; Lee SH; Hwang Y; Yoo H; Jung H; Kim SH; Mok H
Macromol Biosci; 2017 Apr; 17(4):. PubMed ID: 27863037
[TBL] [Abstract][Full Text] [Related]
30. Lipid-based nanoparticles in the systemic delivery of siRNA.
Lin Q; Chen J; Zhang Z; Zheng G
Nanomedicine (Lond); 2014 Jan; 9(1):105-20. PubMed ID: 24354813
[TBL] [Abstract][Full Text] [Related]
31. Tetrahedral Framework Nucleic Acids Loaded with Aptamer AS1411 for siRNA Delivery and Gene Silencing in Malignant Melanoma.
Xiao D; Li Y; Tian T; Zhang T; Shi S; Lu B; Gao Y; Qin X; Zhang M; Wei W; Lin Y
ACS Appl Mater Interfaces; 2021 Feb; 13(5):6109-6118. PubMed ID: 33497198
[TBL] [Abstract][Full Text] [Related]
32. The application of aptamers in cancer research: an up-to-date review.
Hu M; Zhang K
Future Oncol; 2013 Mar; 9(3):369-76. PubMed ID: 23469972
[TBL] [Abstract][Full Text] [Related]
33. Systemic Delivery of Aptamer-Conjugated XBP1 siRNA Nanoparticles for Efficient Suppression of HER2+ Breast Cancer.
Zhang L; Mu C; Zhang T; Wang Y; Wang Y; Fan L; Liu C; Chen H; Shen J; Wei K; Li H
ACS Appl Mater Interfaces; 2020 Jul; 12(29):32360-32371. PubMed ID: 32613835
[TBL] [Abstract][Full Text] [Related]
34. Lipid nanoparticles for targeted siRNA delivery - going from bench to bedside.
Zatsepin TS; Kotelevtsev YV; Koteliansky V
Int J Nanomedicine; 2016; 11():3077-86. PubMed ID: 27462152
[TBL] [Abstract][Full Text] [Related]
35. Current progress on aptamer-targeted oligonucleotide therapeutics.
Dassie JP; Giangrande PH
Ther Deliv; 2013 Dec; 4(12):1527-46. PubMed ID: 24304250
[TBL] [Abstract][Full Text] [Related]
36. Synthetic Polymer Hybridization with DNA and RNA Directs Nanoparticle Loading, Silencing Delivery, and Aptamer Function.
Zhou Z; Xia X; Bong D
J Am Chem Soc; 2015 Jul; 137(28):8920-3. PubMed ID: 26138550
[TBL] [Abstract][Full Text] [Related]
37. Layer-by-layer nanoparticles as an efficient siRNA delivery vehicle for SPARC silencing.
Tan YF; Mundargi RC; Chen MH; Lessig J; Neu B; Venkatraman SS; Wong TT
Small; 2014 May; 10(9):1790-8. PubMed ID: 24510544
[TBL] [Abstract][Full Text] [Related]
38. [Types of non-viral delivery systems of small interfering RNA].
Glebova KV; Marakhonov AV; Baranova AV; Skoblov MIu
Mol Biol (Mosk); 2012; 46(3):387-401. PubMed ID: 22888629
[TBL] [Abstract][Full Text] [Related]
39. Liver-Targeted siRNA Lipid Nanoparticles Treat Hepatic Cirrhosis by Dual Antifibrotic and Anti-inflammatory Activities.
Zhang J; Shen H; Xu J; Liu L; Tan J; Li M; Xu N; Luo S; Wang J; Yang F; Tang J; Li Q; Wang Y; Yu L; Yan Z
ACS Nano; 2020 May; 14(5):6305-6322. PubMed ID: 32378877
[TBL] [Abstract][Full Text] [Related]
40. Targeted decationized polyplexes for siRNA delivery.
Novo L; Takeda KM; Petteta T; Dakwar GR; van den Dikkenberg JB; Remaut K; Braeckmans K; van Nostrum CF; Mastrobattista E; Hennink WE
Mol Pharm; 2015 Jan; 12(1):150-61. PubMed ID: 25384057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
